CNS|CRO offers a new approach to solving neurological diseases using unique animal models that more accurately reflect the progression of neurological disease in humans. Designed to be a preferred provider of pre-clinical contract research, CNS|CRO functions as an independent extension of a client’s pre-clinical process. CNS|CRO provides its clients with focus, expertise and quality customer service with services that are flexible and innovative.

A wholly-owned subsidiary of Neurodyn Inc, CNS|CRO is a pre-clinical contract research organization offering a suite of animal models of neurological disease that are:

• slowly developing and progressive
• environmentally based
• highly predictive
• proprietary
• customizable
• ideal for identification of early stage treatments.

Neurological disease is a large and growing problem – despite billions of research dollars. Currently, the causes of most neurological disease are not fully understood. For the most part, current treatments only help to alleviate the symptoms and current 'standard' animal models often replicate only one aspect of the disease identified in a small minority of the patients. Successful drug development programs require animal models that more faithfully replicate the human disease condition. CNS|CRO is pleased to offer these highly predictive models.

In addition, CNS|CRO also offers numerous cognitive & behavioural tests of neurological disease though a suite of in vitro assays, as well as Zebra fish models for early stage screening. Each test is adaptable, depending on which aspects or learning and/or memory the client is interested in exploring.